Select patient and procedural risk factors to determine complication profile.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Pre-procedural risk assessment for patients undergoing ERCP
To guide the decision for prophylactic rectal NSAIDs or pancreatic duct (PD) stenting
To aid in the informed consent process by quantifying patient-specific risks
Defining PEP
Post-ERCP Pancreatitis is defined as new or worsened abdominal pain with amylase/lipase ≥ 3x ULN at 24 hours post-procedure, requiring at least 2 days of unplanned hospitalization.
Section 2
Formula & Logic
High-Risk Patient Factors
Young age (typically < 50 years)
Female sex
Suspected Sphincter of Oddi Dysfunction (SOD)
History of prior post-ERCP pancreatitis
Normal Total Bilirubin (correlates with small CBD diameter)
High-Risk Procedural Factors
Difficult cannulation (e.g., > 10 attempts or > 10 minutes)
Pancreatic duct (PD) cannulation or contrast injection
Pre-cut sphincterotomy (especially if performed by trainee)
Risk is synergistic. A young female with SOD undergoing a difficult cannulation has a PEP risk approaching 30%, compared to a baseline risk of ~5% in the general population.
Section 3
Pearls/Pitfalls
Prevention Strategy — Rectal NSAIDs
Universal administration of 100mg Rectal Indomethacin (or Diclofenac) pre- or immediately post-ERCP is now a Tier-1 quality metric (ESGE/ASGE). It reduces the relative risk of PEP by approximately 40–50%.
PD Stenting vs. NSAIDs
In extremely high-risk cases (e.g., repeated PD cannulation), rectal NSAIDs alone may be insufficient. Placement of a 3Fr or 5Fr prophylactic pancreatic stent is the gold standard for high-risk prevention.
Clinical Pearls
Aggressive periprocedural hydration (Lactated Ringers) reduces PEP severity but not necessarily incidence
Small CBD diameter (< 5mm) is an independent technical risk factor for "difficult" cannulation and PEP
Double-wire technique for biliary access increases PEP risk unless a PD stent is placed
Section 4
Next Steps
Post-Procedure Action
01
Patient has ≥ 2 High-Risk Factors: Mandatory Rectal Indomethacin and consider 4-hour post-ERCP Amylase check.
02
Amylase at 4h < 1.5x ULN: Excellent negative predictive value (NPV); patient is likely safe for same-day discharge.
03
Significant Post-Op Pain: Admit for observation and IV hydration; do not wait for lipase to rise.
Complementary Tools
Cotton Criteria (Complication Grading)
ASGE Quality Indicators for ERCP
Tokyo Guidelines (Cholangitis)
Section 5
Evidence Appraisal
Core Risk Factors study
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.
Freeman ML et al. • Gastrointestinal Endoscopy. 2001;54(4):425-34. Large-scale multicenter study defining modern risk groups.
The primary risk factors were refined through collaborative research led by Martin Freeman (Minnesota) and Greg Lehman (Indianna). Their work moved ERCP from an "unpredictable" procedure to one where high-risk subsets could be identified and protected through advanced stenting and pharmacotherapy.
